BR112013022237A2 - uso de fluido viscoelástico para produzir produto medicinal para tratar cirurgicamente o olho - Google Patents

uso de fluido viscoelástico para produzir produto medicinal para tratar cirurgicamente o olho

Info

Publication number
BR112013022237A2
BR112013022237A2 BR112013022237A BR112013022237A BR112013022237A2 BR 112013022237 A2 BR112013022237 A2 BR 112013022237A2 BR 112013022237 A BR112013022237 A BR 112013022237A BR 112013022237 A BR112013022237 A BR 112013022237A BR 112013022237 A2 BR112013022237 A2 BR 112013022237A2
Authority
BR
Brazil
Prior art keywords
eye
viscoelastic fluid
medicinal product
produce
surgically treat
Prior art date
Application number
BR112013022237A
Other languages
English (en)
Inventor
Oliver Findl
Original Assignee
Croma Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45808917&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013022237(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Croma Pharma Gmbh filed Critical Croma Pharma Gmbh
Publication of BR112013022237A2 publication Critical patent/BR112013022237A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

resumo patente de invenção: "uso de fluido viscoelástico para produzir produto medicinal para tratar cirurgicamente o olho". a presente invenção refere-se ao uso de um fluido viscoelástico aquoso para produzir um produto medicinal para o tratamento cirúrgico do olho, em que o fluido produz um efeito de ampliação óptica das lentes e da pupila mediante aplicação sobre a superfície do olho de um receptáculo de dose única. o fluido viscoelástico compreende pelo menos um polímero fisiologicamente aceitável aumentando a viscosidade selecionado do grupo consistindo em hidroxipropilmetil celulose, carboximetil celulose, hidroxietil celulose, ácido hialurônico, alginato de sódio, hidroxilpropil guar polivinilpirrolidona, polivinil álcool, ácido polimetacrílico (carbômero), copolímerode polioxietileno polioxipropileno (poloxâmero) e polietileno glicol, em uma concentração de 0,01-30%.
BR112013022237A 2011-03-03 2012-03-05 uso de fluido viscoelástico para produzir produto medicinal para tratar cirurgicamente o olho BR112013022237A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATA288/2011A AT511164A1 (de) 2011-03-03 2011-03-03 Verwendung eines viskoelastischen fluids zur herstellung eines medizinproduktes für die chirurgische behandlung des auges
PCT/EP2012/053710 WO2012117115A2 (de) 2011-03-03 2012-03-05 Verwendung eines viskoelastischen fluids zur herstellung eines medizinproduktes für die chirurgische behandlung des auges

Publications (1)

Publication Number Publication Date
BR112013022237A2 true BR112013022237A2 (pt) 2016-12-06

Family

ID=45808917

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013022237A BR112013022237A2 (pt) 2011-03-03 2012-03-05 uso de fluido viscoelástico para produzir produto medicinal para tratar cirurgicamente o olho

Country Status (17)

Country Link
US (1) US20130338240A1 (pt)
EP (1) EP2680817B1 (pt)
JP (1) JP2014506911A (pt)
KR (1) KR20140044780A (pt)
CN (1) CN103547257B (pt)
AT (1) AT511164A1 (pt)
AU (1) AU2012222308B2 (pt)
BR (1) BR112013022237A2 (pt)
CA (1) CA2825485C (pt)
CL (1) CL2013002107A1 (pt)
ES (1) ES2587510T3 (pt)
HU (1) HUE029708T2 (pt)
IL (1) IL228093A (pt)
MX (1) MX342397B (pt)
PL (1) PL2680817T3 (pt)
RU (1) RU2603489C2 (pt)
WO (1) WO2012117115A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3193832B1 (en) * 2015-06-17 2019-08-07 AL.CHI.MI.A. S.r.l. Viscoelastic preparation for use in surgical methods of ophthalmic surgery
ITUB20154802A1 (it) * 2015-10-20 2017-04-20 Medivis S R L Composizione oftalmica
CN105816477A (zh) * 2016-02-29 2016-08-03 李志伟 一种角膜表面保护剂在全麻手术中的应用
CN105749360B (zh) * 2016-03-28 2019-06-18 赛克赛斯生物科技股份有限公司 一种保护角膜的组合物及其制备方法与应用
CN107812243A (zh) * 2017-09-21 2018-03-20 李春晖 一种角膜保护粘弹液
JP7229262B2 (ja) * 2017-11-22 2023-02-27 ボシュ・アンド・ロム・インコーポレイテッド 眼科用粘弾性組成物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4819617A (en) * 1986-09-04 1989-04-11 University Of Florida Viscoelastic material for ophthalmic surgery
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
US6271216B1 (en) * 1989-07-24 2001-08-07 Allergan Stable solution of hyaluronate in a balanced salt medium
DE69017559T3 (de) 1989-07-24 2002-06-06 Allergan Pharmaceuticals Irela Stabile Lösung von Hyaluronat in einem isotonen Salzmilieu.
EP0510270A1 (en) * 1991-04-25 1992-10-28 LINDSTROM, Richard L. Viscoelastic solution
JPH05310580A (ja) 1992-04-30 1993-11-22 Shiseido Co Ltd 眼内灌流用液剤
IT1273011B (it) 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
US6277365B1 (en) 1997-09-18 2001-08-21 Bausch & Lomb Incorporated Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
DE19853007C2 (de) * 1998-11-17 2000-11-30 Matthias Meyer Hyaluronsäure enthaltende Irrigationslösung für Operationen am Auge
JP2002193815A (ja) * 2000-12-25 2002-07-10 Ophtecs Corp 眼手術用角膜乾燥防止点眼剤
WO2003000231A1 (en) * 2001-06-22 2003-01-03 Alcon, Inc. Hydration compositions for corneal pre-surgery treatment
US20040137079A1 (en) 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
CN1524579B (zh) * 2003-02-27 2010-04-28 李俊 复合粘弹剂
US20060073184A1 (en) * 2004-09-29 2006-04-06 Bausch & Lomb Inc. Viscoelastic composition, methods of use and packaging device with anti-oxidant
ITMI20052036A1 (it) 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
DE102005055275A1 (de) 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
RU2600863C2 (ru) * 2007-12-10 2016-10-27 Сентисс Фарма Прайвит Лимитед Офтальмическая композиция, включающая фенилэфрин
CN101676319A (zh) * 2008-09-19 2010-03-24 上海建华精细生物制品有限公司 注射级医用透明质酸钠凝胶
ITRM20090102U1 (it) 2009-06-15 2010-12-16 Alfa Intes Ind Terapeutica Splendore S R L Ialuvit preparato per la stabilizzazione del film lacrimale, la cicatrizzazione corneale e il ripristino del contenuto salino della lacrima e osmoprotezione.

Also Published As

Publication number Publication date
CN103547257B (zh) 2016-05-18
KR20140044780A (ko) 2014-04-15
WO2012117115A2 (de) 2012-09-07
MX342397B (es) 2016-09-28
JP2014506911A (ja) 2014-03-20
ES2587510T3 (es) 2016-10-25
US20130338240A1 (en) 2013-12-19
AT511164A1 (de) 2012-09-15
MX2013009984A (es) 2014-02-17
RU2013141546A (ru) 2015-04-10
IL228093A0 (en) 2013-09-30
RU2603489C2 (ru) 2016-11-27
WO2012117115A3 (de) 2013-01-10
CL2013002107A1 (es) 2014-05-09
AU2012222308B2 (en) 2017-04-06
PL2680817T3 (pl) 2016-12-30
AU2012222308A1 (en) 2013-08-22
EP2680817B1 (de) 2016-05-25
IL228093A (en) 2016-07-31
CN103547257A (zh) 2014-01-29
CA2825485C (en) 2017-07-18
CA2825485A1 (en) 2012-09-07
HUE029708T2 (en) 2017-03-28
EP2680817A2 (de) 2014-01-08

Similar Documents

Publication Publication Date Title
BR112013022237A2 (pt) uso de fluido viscoelástico para produzir produto medicinal para tratar cirurgicamente o olho
JP6242998B2 (ja) 眼科用水性組成物
JP2018090646A (ja) 眼科用組成物
BR112015013774A2 (pt) membrana de hidrogel para prevenção de adesão
RU2017129247A (ru) Способы и композиции для лечения болезни сухого глаза и других глазных заболеваний
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
BR112015021470A2 (pt) conjugado de polímero para administração de um agente bioativo
AR089962A1 (es) Composiciones farmaceuticas oftalmicas y metodos para su elaboracion y uso
ES2570856T3 (es) Composiciones oftálmicas que contienen una combinación sinérgica de dos polímeros
BR112015032545A2 (pt) lentes intraoculares de polímero de memória de formato
JP5616620B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP7304282B2 (ja) カラーコンタクトレンズ用眼科組成物
EP2653155A1 (en) Ophthalmic composition for contact lens
JP2019142979A (ja) 水性液剤
BR112015017246A8 (pt) composição farmacêutica aquosa, seu uso e seringa
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
RU2014146519A (ru) Хондроитин для применения в медицине
AR098201A1 (es) Composiciones de liberación continua basadas sobre ácido hialurónico y aplicaciones terapéuticas de esas composiciones
BR112016002342A8 (pt) microesfera entecavir, método para preparação de uma microesfera entecavir, e, composição farmacêutica
AR079696A1 (es) Composiciones farmacéuticas que comprenden bimatoprost, brimonidina y timolol y su uso para preparar un medicamento util para reducir la presion intraocular
JP2015034166A (ja) 眼科組成物
JP7228119B2 (ja) ソフトコンタクトレンズ用処理液
WO2017151664A1 (en) Pharmaceutical compositions for fluoroquinolone drug delivery
TW201722438A (zh) 眼科組成物
CN105530936B (zh) 两性离子性软隐形眼镜用眼科用组合物

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: VALEANT SP. Z O.O. SP. J. (PL)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL